HYPD
Hyperion DeFi Inc.

5,241
Loading...
Loading...
Hyperion DeFi, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

What is Market Cap of Hyperion DeFi Inc.?
What is the 52-week high for Hyperion DeFi Inc.?
What is the 52-week low for Hyperion DeFi Inc.?
What is Hyperion DeFi Inc. stock price today?
What was Hyperion DeFi Inc. stock price yesterday?
What is the PE ratio of Hyperion DeFi Inc.?
What is the Price-to-Book ratio of Hyperion DeFi Inc.?
What is the 50-day moving average of Hyperion DeFi Inc.?
How many employess does Hyperion DeFi Inc. has?

Latest HYPD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.